Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the ...

The HIV protease inhibitor combo Kaletra (lopinavir/ritonavir) appears no more effective than standard supportive care for people with the new coronavirus, according to the results from one of the ...

With much still to be learned about the new coronavirus, experts are offering recommendations for people at higher risk for severe complications and making provisions for vulnerable populations. At ...

New research employing mRNA technology — which gained prominence during the COVID-19 pandemic — may offer the key to developing a cure for HIV. One of the chief challenges in combating HIV is the ...

Chinese health authorities are testing an HIV drug, lopinavir and ritonavir, as a potential treatment for the new coronavirus; a debate is growing over the efficacy of the sole drug approved to ...

JOHANNESBURG (Thomson Reuters Foundation) - Coronavirus lockdowns have hindered the fight against HIV infection in women and girls globally by limiting their access to education and protection from ...

A 34-year-old male patient was admitted to the hospital with fever and chest pain. His medical history included conditions such as HIV infection, hepatitis C, and tuberculosis. A CT scan showed ...

For the best experience, please enable JavaScript in your browser settings. Hopes for a coronavirus treatment have been raised, after a trial found that an HIV drug ...

HIV researchers in Australia have figured out a way to make the virus visible in white blood cells using mRNA, something that could lead to an eventual cure. Researchers from the Peter Doherty ...

Médecins Sans Frontières (MSF) has been fighting the dual HIV/TB epidemic in Eswatini since 2007. Dr Bernhard Kerschberger, MSF Head of Mission in Eswatini, describes the challenges his team face ...

CROI 2025 will cover viral infections, treatments, and potential cures, focusing on HIV, COVID-19, STIs, and hepatitis C. The conference will feature plenary sessions on HIV research, global ...